Nav: Home

Incarceration linked to excess burden of cancer, new study finds

February 22, 2017

TORONTO, Feb. 22, 2017 -- People who spend time in jails and prisons are more likely to develop certain types of cancer than the general population in Ontario, according to a study published today in the open-access journal PLOS ONE.

They were also more than 50 per cent more likely to die from cancer than the general population in Ontario, the study found. Men were more than three times as likely as men in the general population to die from head and neck and liver cancer and women were three times as likely as women in the general population to die from cervical cancer.

Dr. Fiona Kouyoumdjian, a researcher at St. Michael's Hospital and McMaster University and lead author of the study, said the findings could be the result of high rates of risk factors for cancer in this population.

"We know that people who spend time in jails and prisons in Canada are more likely to use alcohol and tobacco, as well as have infections such as HPV (human papillomavirus) and HIV, which can increase the risk of developing some types of cancer," she said.

The researchers followed almost 50,000 people who were admitted to provincial jails in Ontario in 2000 to study how many people developed cancer and how many people died from cancer over a 12-year period.

Between 2000 and 2012, 2.6 per cent of men and 2.8 per cent of women who spent time in jail or prison were diagnosed with new cancers. The most common types of cancer for men were lung, prostate, colorectal and head and neck, while the most common types of cancer for women were breast, lung and cervical.

Over the followup period, 1.1 per cent of men and 0.9 per cent of women who spent time in jail or prison died from cancer. Adjusted for age, the mortality rate was 1.6 times higher for men and 1.4 times higher for women in this population compared to the general population in Ontario. The mortality rate was higher in men for any cancer, lung cancer, liver cancer, and head and neck cancer, and in women for lung, liver and head and neck cancers compared to the general population.

Dr. Kouyoumdjian said the study showed that cancer prevention efforts should include people who have spent time in jails or prisons.

"Incarceration represents a chance to help people improve their health through the provision of services and linkage with programs in the community," she said.

"Specific strategies that could prevent cancer in this population include smoking cessation, vaccination for HPV and HBV, pap screening and treatment for hepatitis C, and these strategies could have a large impact given that many people who experience incarceration are quite young."
-end-
About St. Michael's Hospital

St. Michael's Hospital provides compassionate care to all who enter its doors. The hospital also provides outstanding medical education to future health care professionals in 27 academic disciplines. Critical care and trauma, heart disease, neurosurgery, diabetes, cancer care, care of the homeless and global health are among the hospital's recognized areas of expertise. Through the Keenan Research Centre and the Li Ka Shing International Healthcare Education Centre, which make up the Li Ka Shing Knowledge Institute, research and education at St. Michael's Hospital are recognized and make an impact around the world. Founded in 1892, the hospital is fully affiliated with the University of Toronto.

Media contacts

For media inquiries, please contact:

Kelly O'Brien
Communications Adviser - Media, St. Michael's Hospital
416-864-5047
obrienkel@smh.ca

St. Michael's Hospital

Related Cancer Articles:

Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
Cancer genomics continued: Triple negative breast cancer and cancer immunotherapy
Continuing PLOS Medicine's special issue on cancer genomics, Christos Hatzis of Yale University, New Haven, Conn., USA and colleagues describe a new subtype of triple negative breast cancer that may be more amenable to treatment than other cases of this difficult-to-treat disease.
Metabolite that promotes cancer cell transformation and colorectal cancer spread identified
Osaka University researchers revealed that the metabolite D-2-hydroxyglurate (D-2HG) promotes epithelial-mesenchymal transition of colorectal cancer cells, leading them to develop features of lower adherence to neighboring cells, increased invasiveness, and greater likelihood of metastatic spread.
UH Cancer Center researcher finds new driver of an aggressive form of brain cancer
University of Hawai'i Cancer Center researchers have identified an essential driver of tumor cell invasion in glioblastoma, the most aggressive form of brain cancer that can occur at any age.
UH Cancer Center researchers develop algorithm to find precise cancer treatments
University of Hawai'i Cancer Center researchers developed a computational algorithm to analyze 'Big Data' obtained from tumor samples to better understand and treat cancer.
New analytical technology to quantify anti-cancer drugs inside cancer cells
University of Oklahoma researchers will apply a new analytical technology that could ultimately provide a powerful tool for improved treatment of cancer patients in Oklahoma and beyond.
Radiotherapy for lung cancer patients is linked to increased risk of non-cancer deaths
Researchers have found that treating patients who have early stage non-small cell lung cancer with a type of radiotherapy called stereotactic body radiation therapy is associated with a small but increased risk of death from causes other than cancer.
Cancer expert says public health and prevention measures are key to defeating cancer
Is investment in research to develop new treatments the best approach to controlling cancer?
UI Cancer Center, Governors State to address cancer disparities in south suburbs
The University of Illinois Cancer Center and Governors State University have received a joint four-year, $1.5 million grant from the National Cancer Institute to help both institutions conduct community-based research to reduce cancer-related health disparities in Chicago's south suburbs.
Leading cancer research organizations to host international cancer immunotherapy conference
The Cancer Research Institute, the Association for Cancer Immunotherapy, the European Academy of Tumor Immunology, and the American Association for Cancer Research will join forces to sponsor the first International Cancer Immunotherapy Conference at the Sheraton New York Times Square Hotel in New York, Sept.

Related Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Setbacks
Failure can feel lonely and final. But can we learn from failure, even reframe it, to feel more like a temporary setback? This hour, TED speakers on changing a crushing defeat into a stepping stone. Guests include entrepreneur Leticia Gasca, psychology professor Alison Ledgerwood, astronomer Phil Plait, former professional athlete Charly Haversat, and UPS training manager Jon Bowers.
Now Playing: Science for the People

#524 The Human Network
What does a network of humans look like and how does it work? How does information spread? How do decisions and opinions spread? What gets distorted as it moves through the network and why? This week we dig into the ins and outs of human networks with Matthew Jackson, Professor of Economics at Stanford University and author of the book "The Human Network: How Your Social Position Determines Your Power, Beliefs, and Behaviours".